Stocks and Investing
Stocks and Investing
Fri, October 13, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, October 12, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Reni Benjamin Initiated (VYGR) at Buy and Held Target at $35 on, Oct 12th, 2017
Reni Benjamin of Raymond James, Initiated "Voyager Therapeutics, Inc." (VYGR) at Buy and Held Target at $35 on, Oct 12th, 2017.
Reni has made no other calls on VYGR in the last 4 months.
There are 2 other peers that have a rating on VYGR. Out of the 2 peers that are also analyzing VYGR, 0 agree with Reni's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Reni
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $21 on, Thursday, August 17th, 2017
- Katherine Breedis of "Stifel" Initiated at Strong Buy and Held Target at $20 on, Friday, July 28th, 2017